Errata: Vol. 59, No. 20
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Errata: Vol. 59, No. 20

  • September 17, 2010

  • Source: MMWR Morb Mortal Wkly Rep. 2010 Sep 10;59(36);1184
Filetype[PDF-140.45 KB]


English
Details Supporting Files Related Documents You May Also Like

Details:

  • Description:
    In the report "FDA Licensure of Bivalent Human PapillomaVirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)," the second footnote under Table 2 should read as follows: "Phase III trial. According to protocol efficacy Analysis included females aged 15 through 25 years who received all 3 vaccine doses, were seronegative at day 1 and HPV DNA negative at day 1 through month 6 for the respective HPV type, and had normal or low grade cytology at day 1, with case counting beginning 1 day after third vaccine dose; mean duration of follow-up post third vaccine dose: 34.9 months."
  • Subjects:
  • Source:
    MMWR Morb Mortal Wkly Rep. 2010 Sep 10;59(36);1184
  • Document Type:
    Journal Article
  • Genre:
    Published Erratum
  • Volume:
    59
  • Issue:
    36
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

More +

Related Documents

You May Also Like

Checkout today's featured content at stacks.cdc.gov